ZA9781B - Resolution of galanthamine. - Google Patents
Resolution of galanthamine.Info
- Publication number
- ZA9781B ZA9781B ZA9700081A ZA9781A ZA9781B ZA 9781 B ZA9781 B ZA 9781B ZA 9700081 A ZA9700081 A ZA 9700081A ZA 9781 A ZA9781 A ZA 9781A ZA 9781 B ZA9781 B ZA 9781B
- Authority
- ZA
- South Africa
- Prior art keywords
- galanthamine
- pct
- date jul
- enantiomerically
- sec
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title abstract 9
- HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 title abstract 4
- LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003980 galantamine Drugs 0.000 title abstract 4
- BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 title abstract 4
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title abstract 4
- IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Glass Compositions (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600080.7A GB9600080D0 (en) | 1996-01-04 | 1996-01-04 | Resolution process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9781B true ZA9781B (en) | 1998-01-06 |
Family
ID=10786571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9700081A ZA9781B (en) | 1996-01-04 | 1997-01-06 | Resolution of galanthamine. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6087495A (de) |
| EP (1) | EP0880525B1 (de) |
| AT (1) | ATE227725T1 (de) |
| AU (1) | AU700997B2 (de) |
| CA (1) | CA2239814C (de) |
| DE (1) | DE69717076T2 (de) |
| DK (1) | DK0880525T3 (de) |
| ES (1) | ES2186862T3 (de) |
| GB (1) | GB9600080D0 (de) |
| PT (1) | PT880525E (de) |
| WO (1) | WO1997025330A1 (de) |
| ZA (1) | ZA9781B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2310926C (en) * | 2000-04-03 | 2002-10-15 | Janssen Pharmaceutica N.V. | A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| WO2005065662A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Solid dosage formulations of galantamine |
| WO2005065661A2 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Immediate, controlled and sustained release formulations of galanthamine |
| WO2006013546A2 (en) * | 2004-07-28 | 2006-02-09 | Ranbaxy Laboratories Limited | Process for the preparation of pure galantamine |
| CN102050826B (zh) * | 2010-12-21 | 2012-11-14 | 浙江工业大学 | 一种分离加兰他敏的方法 |
| KR101834104B1 (ko) | 2014-01-15 | 2018-03-02 | 엑손모빌 케미칼 패턴츠 인코포레이티드 | 프로필렌계 내충격성 공중합체 |
| US11370902B2 (en) | 2017-09-11 | 2022-06-28 | Exxonmobil Chemical Patents Inc. | Articles comprising polypropylene impact copolymers and methods of making the same |
| WO2022015627A2 (en) | 2020-07-17 | 2022-01-20 | Exxonmobil Chemical Patents Inc. | Polymers with low levels of volatile organic compounds and methods of making such polymers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1996
- 1996-01-04 GB GBGB9600080.7A patent/GB9600080D0/en active Pending
-
1997
- 1997-01-06 CA CA002239814A patent/CA2239814C/en not_active Expired - Lifetime
- 1997-01-06 ZA ZA9700081A patent/ZA9781B/xx unknown
- 1997-01-06 DK DK97900276T patent/DK0880525T3/da active
- 1997-01-06 AU AU13867/97A patent/AU700997B2/en not_active Expired
- 1997-01-06 ES ES97900276T patent/ES2186862T3/es not_active Expired - Lifetime
- 1997-01-06 US US09/101,174 patent/US6087495A/en not_active Expired - Lifetime
- 1997-01-06 EP EP97900276A patent/EP0880525B1/de not_active Expired - Lifetime
- 1997-01-06 AT AT97900276T patent/ATE227725T1/de active
- 1997-01-06 DE DE69717076T patent/DE69717076T2/de not_active Expired - Lifetime
- 1997-01-06 PT PT97900276T patent/PT880525E/pt unknown
- 1997-01-06 WO PCT/GB1997/000023 patent/WO1997025330A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ATE227725T1 (de) | 2002-11-15 |
| EP0880525B1 (de) | 2002-11-13 |
| US6087495A (en) | 2000-07-11 |
| AU700997B2 (en) | 1999-01-14 |
| PT880525E (pt) | 2003-03-31 |
| GB9600080D0 (en) | 1996-03-06 |
| DE69717076D1 (de) | 2002-12-19 |
| DK0880525T3 (da) | 2003-03-03 |
| CA2239814A1 (en) | 1997-07-17 |
| AU1386797A (en) | 1997-08-01 |
| EP0880525A1 (de) | 1998-12-02 |
| ES2186862T3 (es) | 2003-05-16 |
| DE69717076T2 (de) | 2003-07-17 |
| CA2239814C (en) | 2006-08-29 |
| WO1997025330A1 (en) | 1997-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102474A (en) | (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate | |
| GR3036305T3 (en) | Chiral methyl phenyl oxazolidinones | |
| ZA974216B (en) | Process for the resolution of racemic ketamine. | |
| GB9600080D0 (en) | Resolution process | |
| GR3032521T3 (en) | Process for the hydrogenation of imines | |
| BG103649A (en) | Method for the preparation of eprosartan | |
| ZA963132B (en) | Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine. | |
| GB9614804D0 (en) | Resolution process | |
| IL132623A0 (en) | Process for making 2-(trihaloacetyl)-3-(substituted amino)-2-propenoates | |
| HUP9901713A3 (en) | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid | |
| AU694653B2 (en) | D4T polymorphic form I process | |
| MY117754A (en) | Stereoselective process for producing dihydro-2, 3-benzodiazepine derivatives | |
| HUP9902443A3 (en) | New process for making phenyl substituted 2(5h)-furanones, intermediates | |
| GB9318790D0 (en) | Heterocyclic derivatives | |
| AU3055397A (en) | Heterocyclic compounds | |
| HUP0001926A3 (en) | A process for the crystallization of lactitol | |
| ZA963192B (en) | Process for making heterocyclic compounds. | |
| GR3032175T3 (en) | IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH. | |
| SE9404438D0 (sv) | New process | |
| EG20542A (en) | Process for preparing of benzopyrons compounds | |
| FR2685330B1 (fr) | Procede de preparation des enantiomeres d'un derive de l'isoindolinone. | |
| EP0859758A4 (de) | ||
| IE891895L (en) | 2-amino-7-hydroxytetraline ethers | |
| FR2708203B1 (fr) | Procédé d'inhibition de la perception des odeurs. | |
| IL123602A0 (en) | Salts of 2,3,4,5-Tetrahydro-1H-3-Benzazepine compounds |